Clinical Trial Update: NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating NAD augmentation to prevent or reverse Alzheimer's disease in people with Down syndrome; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Down Syndrome

Drugs mentioned

• NAD+ augmentation

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Down Syndrome (DS) | Phase 1 | Status: NOT_YET_RECRUITING